Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound

Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives Opioid δ1 receptor antagonist 7-benzylidenenaltrexone as an effective resistance reverser for chloroquine-resistant Plasmodium chabaudi Parallel methods for the preparation and SAR exploration of N-ethyl-4-[(8-alkyl-8-aza-bicyclo[3.2.1]oct-3-ylidene)-aryl-methyl]-benzamides, powerful mu and delta opioid agonists Structure−Antitussive Activity Relationships of Naltrindole Derivatives. Identification of Novel and Potent Antitussive Agents Discovery of a Potent and Efficacious Peptide Derivative for δ/μ Opioid Agonist/Neurokinin 1 Antagonist Activity with a 2′,6′-Dimethyl-<scp>l</scp>-Tyrosine: In vitro, In vivo, and NMR-Based Structural Studies Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons Conversion of the Potent δ-Opioid Agonist H-Dmt-Tic-NH-CH₂-Bid into δ-Opioid Antagonists by N-Benzimidazole Alkylation¹ Benzylideneoxymorphone: A new lead for development of bifunctional mu/delta opioid receptor ligands Aminotetralins as narcotic antagonists. Synthesis and opiate-related activity of 1-phenyl-1-aminotetralin derivatives